Search filters

List of works by Ioannis Parodis

2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

scientific article published on 27 March 2020

ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus

scientific article published on 13 November 2019

Antiphospholipid Antibodies in Lupus Nephritis

scientific article

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

scientific article published on 14 May 2020

Biologics in SLE: towards new approaches.

scientific article published on June 2013

Clinical Reasoning Needs to Be Explicitly Addressed in Health Professions Curricula: Recommendations from a European Consortium

scientific article published on 25 October 2021

Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies

scientific article published on 27 December 2018

Creating Virtual Patients using Robots and Large Language Models: A Preliminary Study with Medical Students

scientific article published on 11 March 2024

Established organ damage reduces belimumab efficacy in systemic lupus erythematosus

scientific article published on 04 January 2019

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy

scientific article

How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

scientific article published on 10 May 2019

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus

scientific article published in 2022

Increasing Reasoning Awareness: Video Analysis of Students' Two-Party Virtual Patient Interactions.

scientific article published on 27 February 2018

Interferon (IFN)-λ is a potential mediator in lupus nephritis

scientific article

Prediction of prognosis and renal outcome in lupus nephritis

scientific article published on 18 February 2020

Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus

scientific article published on 01 December 2019

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL.

scientific article

Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

scientific article published on 15 December 2016

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

scientific article published on 12 February 2017

Smoking reduces the efficacy of belimumab in mucocutaneous lupus

scientific article published on 09 July 2018

The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus

scientific article published on 01 June 2019

Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus

scientific article published on 10 June 2020